Keywords: teva, avapro, anda, filing, does, challenge, sanofi

Teva's Avapro ANDA filing "does not challenge" Sanofi's patent

Article | 26 July 2004

Print This

Following the filing in the USA of an Abbreviated New Drug Applicationfor a generic version of Avapro (irbesartan) by Israel-headquartered ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in